| 國立成功大學 |
2021-07-13 |
適用於超音波觸覺之壓電式微型超音波傳感器的初步探討
|
蘇芯儀; Su, Hsin-Yi |
| 國立成功大學 |
2021-07-13 |
以無線網路通道狀態資訊實現應用於健康監測之微小動作偵測與量化
|
Chen, Hui-Hsin; 陳卉芯 |
| 國立成功大學 |
2021-07-13 |
具有各種隔板之封閉倉儲的三維自然對流熱傳特性研究
|
Yu, Tzung-Hua; 余宗樺 |
| 國立成功大學 |
2021-07-13 |
金門受水池中影響微囊藻生長主要因素探討
|
Chin, Hui-San; 陳蕙珊 |
| 國立成功大學 |
2021-07-13 |
探索短片段T細胞淋巴瘤侵襲和轉移蛋白2在阿茲海默氏症中扮演的角色
|
王莉云; Wang, Li-Yun |
| 國立成功大學 |
2021-07-13 |
具兩加熱面之房屋內的三維自然對流熱傳研究
|
Wang, Jou-Hsin; 王柔心 |
| 國立成功大學 |
2021-07-13 |
應用數位影像相關法於聚醯亞胺薄膜三維黏彈性本構模型建立
|
黃嘉鑫; Huang, Jia-Shin |
| 國立成功大學 |
2021-07-13 |
H2O2及 UV對柱孢藻產毒與基因表現之影響
|
潘薇如; Pan, Wei-Ju |
| 國立成功大學 |
2021-07-13 |
以碳氯化結合二階段還原法進行轉爐石脫磷之可行性研究
|
詹豐銘; Chan, Feng-Ming |
| 國立成功大學 |
2021-07-13 |
氧化及鹼度對於微囊藻毒釋出DAB和AEG之影響
|
馬彥維; Madrid, Ephraim Emmanuel |
| 國立成功大學 |
2021-07-13 |
石墨烯類奈米材料對不同極性有機化合物的吸附和吸收雙重作用之研究
|
鄭因軒; Cheng, Yin-Hsuan |
| 中山醫學大學 |
2021-07-13 |
1-Nitropyrene Induced Reactive Oxygen Species-Mediated Apoptosis in Macrophages through AIF Nuclear Translocation and AMPK/Nrf-2/HO-1 Pathway Activation
|
Su, Chun-Hung;Ho, Yung-Chuan;Lee, Min-Wei;Tseng, Ching-Chi;Lee, Shiuan-Shinn;Hsieh, Ming Kun;Chen, Hsin-Hung;Lee, Chien-Ying;Wu, Sheng-Wen;Kuan, Yu-Hsiang |
| 亞洲大學 |
2021-07-13 |
外送平台品質與品牌形象對消費者行為之研究
|
曾玠荁; ZENG, JIE-HUAN |
| 國立成功大學 |
2021-07-13 |
Using Mindful Attention Awareness Scale on male prisoners: Confirmatory factor analysis and Rasch models
|
Poorebrahim;Ali;Lin;Chung-Ying;Imani;Vida;Kolvani;Soltankhah, Shapour;Alaviyoun;Abbas, Seyed;Ehsani;Narges;Pakpour;Amir, H. |
| 國立成功大學 |
2021-07-13 |
Vacuum cathode arc-induced pulsed thruster
|
Li, Yueh-Heng;Liu, Sheng-Wen;Lee, Hou-Yi;Kuo, Tien-Chuan;Hsu, Yao-Chung; 李約亨 |
| 國立成功大學 |
2021-07-13 |
真空陰極電弧誘發脈衝式推進器
|
李約亨 LI, YUEH-HENG;李後毅 LEE, HOU-YI;高健鈞 KAO, CHIEN-CHUN;劉勝文 LIU, SHENG-WEN;郭添全 KUO, TIEN-CHUAN;許耀中 HSU, YAO-CHUNG;黃丙翰 HUANG, PING-HAN |
| 國立成功大學 |
2021-07-13 |
互動式影像標記方法與使用此方法的電子裝置、記錄媒體以及電腦程式產品
|
蔡依珊;TSAI, YI-SHAN;賴政詩;LAI, CHENG-SHIH;陳昭芸;CHEN, CHAO-YUN;吳孟珍;WU, MENG-JHEN;吳芸喬;WU, YUN-CHIAO;馮馨儀;FENG, HSIN-YI;郭柏村;KUO, PO-TSUN;王楷毅;WANG, KAI-YI;蘇威丞;SU, WEI-CHENG |
| 國立成功大學 |
2021-07-13 |
影像分割方法與使用此方法的電子裝置、記錄媒體以及電腦程式產品
|
蔡依珊;TSAI, YI-SHAN;賴政詩;LAI, CHENG-SHIH;陳昭芸;CHEN, CHAO-YUN;吳孟珍;WU, MENG-JHEN;吳芸喬;WU, YUN-CHIAO;馮馨儀;ENG, HSIN-YI;郭柏村;KUO, PO-TSUN;王楷毅;WANG, KAI-YI;蘇威丞;SU, WEI-CHENG |
| 臺大學術典藏 |
2021-07-13T06:04:27Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; LEE JIH-HSIANG; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2021-07-13T06:04:28Z |
Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours
|
de Bono J.; Lin C.-C.; Chen L.-T.; Corral J.; Michalarea V.; Rihawi K.; Ong M.; LEE JIH-HSIANG; Hsu C.-H.; Yang J.C.-H.; Shiah H.-S.; Yen C.-J.; Anthoney A.; Jove M.; Buschke S.; Fuertig R.; Schmid U.; Goeldner R.-G.; Strelkowa N.; Huang D.C.-L.; Bogenrieder T.; Twelves C.; Cheng A.-L. |
| 臺大學術典藏 |
2021-07-13T06:04:29Z |
A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors
|
LEE JIH-HSIANG; Chen T.W.-W.; Hsu C.-H.; Yen Y.-H.; Yang J.C.-H.; Cheng A.-L.; Sasaki S.-I.; Chiu L.Y.; Sugihara M.; Ishizuka T.; Oguma T.; Tajima N.; Lin C.-C. |
| 臺大學術典藏 |
2021-07-13T06:04:30Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; LEE JIH-HSIANG; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2021-07-13T06:04:30Z |
Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors
|
LEE JIH-HSIANG; Chen H.-Y.; Hsu F.-M.; Chen J.-S.; Liao W.-Y.; Shih J.-Y.; Yu C.-J.; Chen K.-Y.; Tsai T.-H.; Yang J.C.-H. |
| 臺大學術典藏 |
2021-07-13T06:04:31Z |
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations
|
Lin Y.-T.; Chen J.-S.; Liao W.-Y.; Ho C.-C.; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; LEE JIH-HSIANG; Lin Z.-Z.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2021-07-13T06:04:32Z |
Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non�VSmall-cell Lung Cancer Patients
|
Wu T.-H.; Hsiue E.H.-C.; LEE JIH-HSIANG; Lin C.-C.; Liao W.-Y.; Ho C.-C.; Shih J.-Y.; Yu C.-J.; Yang J.C.-H. |
